Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-035718)

Filing Details

Accession Number:: 0001181431-13-035718
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-19 15:51:26
Reporting Period:: 2013-06-17

Filing Date:: 2013-06-19
Accepted Time:: 2013-06-19 15:51:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
910267	Titan Pharmaceuticals Inc	TTNP.OB	Biological Products, (No Disgnostic Substances) (2836)	943171940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1412377	Marc Rubin	400 Oyster Point Blvd. Suite 505 So. San Francisco CA 94080	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	Acquisiton	2013-06-17	50,000	$0.45	463,400	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.4490 to $0.4550. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.